| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF821 DUXA ATOH7 CPHXL2 DUX4L9 ISX DUX4L2 DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 MEIS3P1 ZNF705G CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 DUX4L4 | 9.15e-11 | 1459 | 95 | 28 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | DUXA ATOH7 CPHXL2 DUX4L9 ISX DUX4L2 DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 MEIS3P1 ZNF705G CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 DUX4L4 | 2.37e-10 | 1412 | 95 | 27 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF821 ATOH7 CPHXL2 DUX4 MEIS3 RAX2 CXXC1 RAX MEIS1 MEIS2 MEIS3P1 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 | 7.12e-06 | 1271 | 95 | 19 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 MEIS3P1 CRX OTX1 OTX2 MIXL1 DUX1 | 1.38e-05 | 560 | 95 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 MEIS3P1 CRX OTX1 OTX2 MIXL1 DUX1 | 1.54e-05 | 566 | 95 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF821 ATOH7 CPHXL2 DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 MEIS3P1 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 | 2.01e-05 | 1244 | 95 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | nodal binding | 6.16e-04 | 8 | 95 | 2 | GO:0038100 | |
| GeneOntologyBiologicalProcess | visual system development | ATOH7 MEIS3 ITGAM RAX MEIS1 MEIS2 MEIS3P1 CRX FREM2 OTX2 ALMS1 PKNOX1 MFN2 MYOM2 CRYBG3 VSX2 | 4.64e-10 | 483 | 93 | 16 | GO:0150063 |
| GeneOntologyBiologicalProcess | sensory system development | ATOH7 MEIS3 ITGAM RAX MEIS1 MEIS2 MEIS3P1 CRX FREM2 OTX2 ALMS1 PKNOX1 MFN2 MYOM2 CRYBG3 VSX2 | 5.89e-10 | 491 | 93 | 16 | GO:0048880 |
| GeneOntologyBiologicalProcess | eye development | ATOH7 MEIS3 RAX MEIS1 MEIS2 MEIS3P1 CRX FREM2 OTX2 ALMS1 PKNOX1 MFN2 MYOM2 CRYBG3 VSX2 | 3.79e-09 | 480 | 93 | 15 | GO:0001654 |
| GeneOntologyBiologicalProcess | sensory organ development | ATOH7 MEIS3 RAX MEIS1 MEIS2 MEIS3P1 CRX FREM2 OTX1 OTX2 ALMS1 PKNOX1 MFN2 MYOM2 CRYBG3 VSX2 | 1.54e-07 | 730 | 93 | 16 | GO:0007423 |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 2.01e-05 | 2 | 93 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 2.01e-05 | 2 | 93 | 2 | GO:1900123 | |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 2.01e-05 | 2 | 93 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 2.23e-05 | 426 | 93 | 10 | GO:0043010 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 5.73e-05 | 91 | 93 | 5 | GO:0009880 | |
| GeneOntologyBiologicalProcess | cell migration involved in gastrulation | 9.57e-05 | 20 | 93 | 3 | GO:0042074 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.30e-04 | 526 | 93 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ATOH7 DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 MEIS3P1 CRX OTX1 OTX2 MIXL1 PKNOX1 ZFHX3 DUX1 VSX2 AGRN | 1.43e-04 | 1390 | 93 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | diencephalon morphogenesis | 2.98e-04 | 6 | 93 | 2 | GO:0048852 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 4.16e-04 | 7 | 93 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 4.16e-04 | 7 | 93 | 2 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 4.16e-04 | 7 | 93 | 2 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 4.16e-04 | 7 | 93 | 2 | GO:0032799 | |
| MousePheno | microphthalmia | SZT2 MEIS3 CLDN12 RAX MEIS1 KIF7 BEX3 FREM2 OTX2 VSX2 CAPN15 | 1.06e-06 | 362 | 67 | 11 | MP:0001297 |
| MousePheno | abnormal eye size | SZT2 MEIS3 CLDN12 RAX MEIS1 KIF7 BEX3 FREM2 OTX2 VSX2 CAPN15 | 1.49e-06 | 375 | 67 | 11 | MP:0002697 |
| MousePheno | abnormal left renal vein morphology | 2.26e-05 | 2 | 67 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 2.26e-05 | 2 | 67 | 2 | MP:0011323 | |
| MousePheno | absent heart | 3.69e-05 | 14 | 67 | 3 | MP:0011388 | |
| MousePheno | abnormal circardian behavior entrainment | 4.60e-05 | 15 | 67 | 3 | MP:0020476 | |
| MousePheno | abnormal circadian behavior | 5.01e-05 | 84 | 67 | 5 | MP:0020467 | |
| MousePheno | small lens | 6.76e-05 | 46 | 67 | 4 | MP:0001306 | |
| MousePheno | abnormal kidney venous blood vessel morphology | 6.77e-05 | 3 | 67 | 2 | MP:0011311 | |
| MousePheno | abnormal orbit morphology | 8.16e-05 | 18 | 67 | 3 | MP:0010030 | |
| MousePheno | abnormal heart valve morphology | 1.27e-04 | 163 | 67 | 6 | MP:0000285 | |
| MousePheno | abnormal large intestine placement | 1.35e-04 | 4 | 67 | 2 | MP:0003284 | |
| MousePheno | decreased midbrain size | 1.74e-04 | 23 | 67 | 3 | MP:0012089 | |
| MousePheno | abnormal notochord morphology | 2.32e-04 | 63 | 67 | 4 | MP:0002825 | |
| MousePheno | absent heart right ventricle | 3.35e-04 | 6 | 67 | 2 | MP:0003872 | |
| MousePheno | abnormal rhythmic behavior | 4.27e-04 | 204 | 67 | 6 | MP:0021121 | |
| MousePheno | abnormal midbrain size | 4.30e-04 | 31 | 67 | 3 | MP:0012088 | |
| MousePheno | abnormal retina pigment epithelium morphology | 4.66e-04 | 135 | 67 | 5 | MP:0005201 | |
| MousePheno | abnormal trigeminal V mesencephalic nucleus morphology | 4.68e-04 | 7 | 67 | 2 | MP:0000906 | |
| MousePheno | abnormal bronchus morphology | 5.18e-04 | 33 | 67 | 3 | MP:0002264 | |
| MousePheno | abnormal blood circulation | MRGPRD SZT2 CLDN12 MEIS1 MEIS2 CRX FREM2 MGP FBXO41 PKNOX1 PLAT DCBLD2 | 6.06e-04 | 845 | 67 | 12 | MP:0002128 |
| MousePheno | abnormal orbitosphenoid bone morphology | 6.22e-04 | 8 | 67 | 2 | MP:0004457 | |
| MousePheno | left atrial isomerism | 6.22e-04 | 8 | 67 | 2 | MP:0008461 | |
| Domain | Homeobox | DUXA ISX DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 | 9.40e-20 | 234 | 90 | 20 | PF00046 |
| Domain | HOX | DUXA ISX DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 | 1.21e-19 | 237 | 90 | 20 | SM00389 |
| Domain | HOMEOBOX_2 | DUXA ISX DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 | 1.43e-19 | 239 | 90 | 20 | PS50071 |
| Domain | Homeobox_dom | DUXA ISX DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 | 1.43e-19 | 239 | 90 | 20 | IPR001356 |
| Domain | HOMEOBOX_1 | DUXA ISX MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 | 2.66e-18 | 236 | 90 | 19 | PS00027 |
| Domain | - | DUXA ISX DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 SSH3 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX1 VSX2 | 4.09e-18 | 283 | 90 | 20 | 1.10.10.60 |
| Domain | Homeodomain-like | DUXA ISX DUX4 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 SSH3 PKNOX1 TGIF2LX ZFHX3 DUX5 DUX3 DUX1 VSX2 | 5.25e-18 | 332 | 90 | 21 | IPR009057 |
| Domain | PKNOX/Meis_N | 2.32e-12 | 5 | 90 | 5 | IPR032453 | |
| Domain | Meis_PKNOX_N | 2.32e-12 | 5 | 90 | 5 | PF16493 | |
| Domain | Homeobox_KN | 1.25e-10 | 17 | 90 | 6 | PF05920 | |
| Domain | Homeobox_KN_domain | 1.25e-10 | 17 | 90 | 6 | IPR008422 | |
| Domain | Homeobox_CS | 1.49e-09 | 186 | 90 | 11 | IPR017970 | |
| Domain | Otx_TF_C | 1.08e-07 | 3 | 90 | 3 | IPR013851 | |
| Domain | TF_Otx | 1.08e-07 | 3 | 90 | 3 | PF03529 | |
| Domain | HTH_motif | 2.05e-05 | 69 | 90 | 5 | IPR000047 | |
| Domain | LRDF | 2.30e-05 | 2 | 90 | 2 | IPR003942 | |
| Domain | Otx_TF | 2.30e-05 | 2 | 90 | 2 | IPR003025 | |
| Domain | OAR | 2.31e-03 | 15 | 90 | 2 | PF03826 | |
| Domain | OAR | 2.64e-03 | 16 | 90 | 2 | PS50803 | |
| Domain | OAR_dom | 2.64e-03 | 16 | 90 | 2 | IPR003654 | |
| Domain | zf-RanBP | 4.98e-03 | 22 | 90 | 2 | PF00641 | |
| Domain | - | 5.28e-03 | 73 | 90 | 3 | 2.60.120.260 | |
| Domain | ZnF_RBZ | 5.44e-03 | 23 | 90 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 5.44e-03 | 23 | 90 | 2 | PS50199 | |
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | DUX4L2 DUX4 DUX5 DUX3 DUX1 DUX4L5 DUX4L6 DUX4L3 DUX4L4 DUX4L7 | 4.18e-22 | 17 | 99 | 10 | 11245978 |
| Pubmed | 1.58e-18 | 12 | 99 | 8 | 10433963 | ||
| Pubmed | 4.11e-18 | 13 | 99 | 8 | 17668377 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 9.74e-18 | 8 | 99 | 7 | 17588759 | |
| Pubmed | 1.45e-16 | 10 | 99 | 7 | 17984056 | ||
| Pubmed | 2.06e-15 | 13 | 99 | 7 | 7739628 | ||
| Pubmed | The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells. | 4.06e-13 | 24 | 99 | 7 | 20826531 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ZNF821 DUXA ATOH7 ISX MEIS3 RAX MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX VSX2 | 4.37e-11 | 544 | 99 | 15 | 28473536 |
| Pubmed | Identification of a conserved family of Meis1-related homeobox genes. | 6.18e-11 | 4 | 99 | 4 | 9049632 | |
| Pubmed | 7.69e-11 | 11 | 99 | 5 | 18787068 | ||
| Pubmed | 1.29e-10 | 27 | 99 | 6 | 24148613 | ||
| Pubmed | 2.13e-10 | 13 | 99 | 5 | 16847320 | ||
| Pubmed | Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity. | 2.13e-10 | 13 | 99 | 5 | 15576400 | |
| Pubmed | Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development. | 2.13e-10 | 13 | 99 | 5 | 17049510 | |
| Pubmed | 2.63e-10 | 263 | 99 | 11 | 20932939 | ||
| Pubmed | 4.95e-10 | 15 | 99 | 5 | 23756022 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATOH7 ISX BOLA1 MEIS3 RAX2 RAX MEIS1 MEIS2 CRX PKNOX2 OTX1 OTX2 MIXL1 PKNOX1 TGIF2LX ZFHX3 VSX2 | 7.81e-10 | 908 | 99 | 17 | 19274049 |
| Pubmed | Meis1 coordinates a network of genes implicated in eye development and microphthalmia. | 1.40e-09 | 18 | 99 | 5 | 26253404 | |
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 17178831 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 22090505 | ||
| Pubmed | Meis homeoproteins directly regulate Pax6 during vertebrate lens morphogenesis. | 7.70e-09 | 9 | 99 | 4 | 12183364 | |
| Pubmed | GDF11 controls the timing of progenitor cell competence in developing retina. | 8.57e-09 | 25 | 99 | 5 | 15976303 | |
| Pubmed | ATOH7 KDM5C DUX4L9 DUX4L2 TERT CXXC1 RAX MEIS1 MEIS2 CRX OTX1 OTX2 PKNOX1 ZFHX3 DUX4L4 | 9.61e-09 | 808 | 99 | 15 | 20412781 | |
| Pubmed | Otx5 regulates genes that show circadian expression in the zebrafish pineal complex. | 2.24e-08 | 3 | 99 | 3 | 11753388 | |
| Pubmed | CRX is a diagnostic marker of retinal and pineal lineage tumors. | 2.24e-08 | 3 | 99 | 3 | 19936203 | |
| Pubmed | 2.27e-08 | 30 | 99 | 5 | 21451052 | ||
| Pubmed | 4.33e-08 | 13 | 99 | 4 | 27918583 | ||
| Pubmed | Deficient FGF signaling causes optic nerve dysgenesis and ocular coloboma. | 5.93e-08 | 36 | 99 | 5 | 23720040 | |
| Pubmed | Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development. | 6.05e-08 | 14 | 99 | 4 | 14625556 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 9736770 | ||
| Pubmed | QRX, a novel homeobox gene, modulates photoreceptor gene expression. | 8.93e-08 | 4 | 99 | 3 | 15028672 | |
| Pubmed | Intracellular trafficking and dynamics of double homeodomain proteins. | 8.93e-08 | 4 | 99 | 3 | 15709750 | |
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 8.93e-08 | 4 | 99 | 3 | 38509386 | |
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 17911620 | ||
| Pubmed | Stage-dependent requirement of neuroretinal Pax6 for lens and retina development. | 9.00e-08 | 39 | 99 | 5 | 24523460 | |
| Pubmed | 1.09e-07 | 16 | 99 | 4 | 12431380 | ||
| Pubmed | Simultaneous Requirements for Hes1 in Retinal Neurogenesis and Optic Cup-Stalk Boundary Maintenance. | 1.09e-07 | 16 | 99 | 4 | 31949107 | |
| Pubmed | 1.32e-07 | 42 | 99 | 5 | 30485816 | ||
| Pubmed | 1.83e-07 | 18 | 99 | 4 | 17936261 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 20063414 | ||
| Pubmed | 2.23e-07 | 5 | 99 | 3 | 20494911 | ||
| Pubmed | Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiation. | 2.32e-07 | 19 | 99 | 4 | 18697938 | |
| Pubmed | Proper patterning of the optic fissure requires the sequential activity of BMP7 and SHH. | 2.89e-07 | 20 | 99 | 4 | 16854970 | |
| Pubmed | 3.56e-07 | 21 | 99 | 4 | 20237281 | ||
| Pubmed | Extraembryonic proteases regulate Nodal signalling during gastrulation. | 3.56e-07 | 21 | 99 | 4 | 12447384 | |
| Pubmed | 3.56e-07 | 21 | 99 | 4 | 21273545 | ||
| Pubmed | Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo. | 3.56e-07 | 21 | 99 | 4 | 18781635 | |
| Pubmed | Zac1 functions through TGFbetaII to negatively regulate cell number in the developing retina. | 3.56e-07 | 21 | 99 | 4 | 17559664 | |
| Pubmed | 4.34e-07 | 22 | 99 | 4 | 22748019 | ||
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 10603343 | ||
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 19559479 | ||
| Pubmed | Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. | 4.45e-07 | 6 | 99 | 3 | 22987645 | |
| Pubmed | 5.25e-07 | 23 | 99 | 4 | 18691704 | ||
| Pubmed | Disruption of early proximodistal patterning and AVE formation in Apc mutants. | 5.25e-07 | 23 | 99 | 4 | 16887818 | |
| Pubmed | 5.25e-07 | 23 | 99 | 4 | 22792072 | ||
| Pubmed | Precise temporal control of the eye regulatory gene Pax6 via enhancer-binding site affinity. | 7.77e-07 | 7 | 99 | 3 | 20413611 | |
| Pubmed | 7.77e-07 | 7 | 99 | 3 | 12397630 | ||
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 7.77e-07 | 7 | 99 | 3 | 30765463 | |
| Pubmed | The T-box transcription factor Eomesodermin is essential for AVE induction in the mouse embryo. | 8.80e-07 | 26 | 99 | 4 | 23651855 | |
| Pubmed | 8.80e-07 | 26 | 99 | 4 | 19828801 | ||
| Pubmed | 1.03e-06 | 27 | 99 | 4 | 22323600 | ||
| Pubmed | 1.03e-06 | 27 | 99 | 4 | 11566859 | ||
| Pubmed | 1.20e-06 | 28 | 99 | 4 | 23595746 | ||
| Pubmed | Complementary functions of Otx2 and Cripto in initial patterning of mouse epiblast. | 1.20e-06 | 28 | 99 | 4 | 11412024 | |
| Pubmed | TET-mediated DNA demethylation controls gastrulation by regulating Lefty-Nodal signalling. | 1.20e-06 | 28 | 99 | 4 | 27760115 | |
| Pubmed | 1.20e-06 | 28 | 99 | 4 | 16728477 | ||
| Pubmed | 1.20e-06 | 28 | 99 | 4 | 21896628 | ||
| Pubmed | Notch pathway mutants do not equivalently perturb mouse embryonic retinal development. | 1.20e-06 | 28 | 99 | 4 | 37751417 | |
| Pubmed | 1.24e-06 | 8 | 99 | 3 | 19004853 | ||
| Pubmed | Patterning the optic neuroepithelium by FGF signaling and Ras activation. | 1.24e-06 | 8 | 99 | 3 | 11748141 | |
| Pubmed | Canonical Wnt/β-catenin signalling is essential for optic cup formation. | 1.39e-06 | 29 | 99 | 4 | 24324671 | |
| Pubmed | 1.39e-06 | 29 | 99 | 4 | 19474320 | ||
| Pubmed | Requirements for Neurogenin2 during mouse postnatal retinal neurogenesis. | 1.39e-06 | 29 | 99 | 4 | 30048641 | |
| Pubmed | Lhx2 links the intrinsic and extrinsic factors that control optic cup formation. | 1.39e-06 | 29 | 99 | 4 | 19906857 | |
| Pubmed | Sma- and Mad-related protein 7 (Smad7) is required for embryonic eye development in the mouse. | 1.60e-06 | 30 | 99 | 4 | 23426374 | |
| Pubmed | 1.60e-06 | 30 | 99 | 4 | 15459106 | ||
| Pubmed | Phase transition specified by a binary code patterns the vertebrate eye cup. | 1.83e-06 | 31 | 99 | 4 | 34757798 | |
| Pubmed | 1.86e-06 | 9 | 99 | 3 | 10903182 | ||
| Pubmed | Differential expression of retinoic acid-inducible (Stra) genes during mouse placentation. | 1.86e-06 | 9 | 99 | 3 | 10727869 | |
| Pubmed | Genetic dissection of nodal function in patterning the mouse embryo. | 1.86e-06 | 9 | 99 | 3 | 11311163 | |
| Pubmed | Genetic chimeras reveal the autonomy requirements for Vsx2 in embryonic retinal progenitor cells. | 1.86e-06 | 9 | 99 | 3 | 25927996 | |
| Pubmed | No turning, a mouse mutation causing left-right and axial patterning defects. | 2.65e-06 | 10 | 99 | 3 | 9466889 | |
| Pubmed | Disrupting Foxh1-Groucho interaction reveals robustness of nodal-based embryonic patterning. | 2.65e-06 | 10 | 99 | 3 | 25511461 | |
| Pubmed | Mutational screening of 10 genes in Chinese patients with microphthalmia and/or coloboma. | 2.65e-06 | 10 | 99 | 3 | 20057906 | |
| Pubmed | Visceral endoderm mediates forebrain development by suppressing posteriorizing signals. | 2.65e-06 | 10 | 99 | 3 | 10985852 | |
| Pubmed | Identification of a new family of Pbx-related homeobox genes. | 2.65e-06 | 10 | 99 | 3 | 8950991 | |
| Pubmed | 2.65e-06 | 10 | 99 | 3 | 7649373 | ||
| Pubmed | 2.65e-06 | 10 | 99 | 3 | 11069920 | ||
| Pubmed | The Retinal Pigment Epithelium Is a Notch Signaling Niche in the Mouse Retina. | 3.02e-06 | 35 | 99 | 4 | 28402857 | |
| Pubmed | 3.63e-06 | 11 | 99 | 3 | 10518210 | ||
| Pubmed | Natural antisense transcripts associated with genes involved in eye development. | 3.63e-06 | 11 | 99 | 3 | 15703187 | |
| Pubmed | 3.63e-06 | 11 | 99 | 3 | 1363228 | ||
| Pubmed | 3.63e-06 | 11 | 99 | 3 | 31950080 | ||
| Pubmed | 3.80e-06 | 37 | 99 | 4 | 23223288 | ||
| Pubmed | 4.83e-06 | 12 | 99 | 3 | 23028343 | ||
| Pubmed | 4.83e-06 | 12 | 99 | 3 | 9671576 | ||
| Pubmed | 4.83e-06 | 12 | 99 | 3 | 25910836 | ||
| Pubmed | RNF31 MEIS3 RAX MEIS1 MEIS2 PKNOX2 OTX1 OTX2 PKNOX1 ZFHX3 VSX2 | 5.80e-06 | 709 | 99 | 11 | 22988430 | |
| Pubmed | 6.27e-06 | 13 | 99 | 3 | 18268105 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | KDM5C MEIS3 CXXC1 RAX MEIS1 MEIS2 PKNOX2 OTX2 MIXL1 PKNOX1 TGIF2LX VSX2 | 7.60e-06 | 877 | 99 | 12 | 20211142 |
| Interaction | RAX2 interactions | 1.89e-05 | 2 | 88 | 2 | int:RAX2 | |
| Interaction | PBX1 interactions | 3.53e-05 | 85 | 88 | 5 | int:PBX1 | |
| Interaction | PBX4 interactions | 3.73e-05 | 86 | 88 | 5 | int:PBX4 | |
| Interaction | CARTPT interactions | 4.41e-05 | 45 | 88 | 4 | int:CARTPT | |
| Interaction | M1AP interactions | 5.23e-05 | 17 | 88 | 3 | int:M1AP | |
| Interaction | PBX2 interactions | 6.65e-05 | 97 | 88 | 5 | int:PBX2 | |
| Cytoband | 4q35.2 | 2.04e-11 | 27 | 96 | 6 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 1.54e-10 | 117 | 96 | 8 | chr4q35 | |
| Cytoband | 1q42.1 | 2.82e-04 | 12 | 96 | 2 | 1q42.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 6.10e-04 | 183 | 96 | 4 | chr16q22 | |
| Cytoband | 9q34.13 | 8.85e-04 | 21 | 96 | 2 | 9q34.13 | |
| Cytoband | 16q22.2 | 9.73e-04 | 22 | 96 | 2 | 16q22.2 | |
| Cytoband | 2p13 | 1.06e-03 | 23 | 96 | 2 | 2p13 | |
| Cytoband | 2p14 | 1.93e-03 | 31 | 96 | 2 | 2p14 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | DUXA DUX4L9 ISX DUX4L2 RAX2 RAX CRX OTX1 OTX2 MIXL1 DUX4L5 VSX2 DUX4L6 DUX4L3 DUX4L4 DUX4L7 | 1.31e-22 | 92 | 71 | 16 | 521 |
| GeneFamily | TALE class homeoboxes and pseudogenes | 6.59e-12 | 26 | 71 | 7 | 526 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.68e-09 | 197 | 90 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.23e-09 | 199 | 90 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-08 | 176 | 90 | 7 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.07e-08 | 176 | 90 | 7 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-07 | 194 | 90 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-07 | 195 | 90 | 7 | 8a04f0e92d10a368ccda5f566ae67ef51f1d34a9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.63e-07 | 199 | 90 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.69e-07 | 200 | 90 | 7 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.72e-06 | 179 | 90 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-06 | 187 | 90 | 6 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 188 | 90 | 6 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 188 | 90 | 6 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 189 | 90 | 6 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 189 | 90 | 6 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-06 | 189 | 90 | 6 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 191 | 90 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.51e-06 | 191 | 90 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 191 | 90 | 6 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-06 | 192 | 90 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-06 | 192 | 90 | 6 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-06 | 195 | 90 | 6 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 195 | 90 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-06 | 195 | 90 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-06 | 197 | 90 | 6 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-06 | 198 | 90 | 6 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.17e-06 | 199 | 90 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 200 | 90 | 6 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.13e-05 | 165 | 90 | 5 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-05 | 168 | 90 | 5 | 74d6dbf9295933acdee785af9b73a94377d15412 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.39e-05 | 169 | 90 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 170 | 90 | 5 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 170 | 90 | 5 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 170 | 90 | 5 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.60e-05 | 172 | 90 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-05 | 178 | 90 | 5 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.15e-05 | 179 | 90 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 180 | 90 | 5 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.24e-05 | 180 | 90 | 5 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.41e-05 | 182 | 90 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | 3'_v3-blood-Hematopoietic_Erythro-Mega|blood / Manually curated celltypes from each tissue | 3.41e-05 | 182 | 90 | 5 | 3100165c5ba8c3016f9a2f7a8e4ea136750823fe | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.50e-05 | 183 | 90 | 5 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 185 | 90 | 5 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 185 | 90 | 5 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 185 | 90 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 185 | 90 | 5 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.88e-05 | 187 | 90 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-05 | 187 | 90 | 5 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.08e-05 | 189 | 90 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.19e-05 | 190 | 90 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 191 | 90 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.29e-05 | 191 | 90 | 5 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 191 | 90 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 192 | 90 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 192 | 90 | 5 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 192 | 90 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 192 | 90 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 192 | 90 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 193 | 90 | 5 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.51e-05 | 193 | 90 | 5 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 193 | 90 | 5 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 194 | 90 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.62e-05 | 194 | 90 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 194 | 90 | 5 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 194 | 90 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 194 | 90 | 5 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.74e-05 | 195 | 90 | 5 | def0a3fb36eec6fbb08e1323baf2b22b28bf751a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-05 | 196 | 90 | 5 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.97e-05 | 197 | 90 | 5 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-05 | 197 | 90 | 5 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-05 | 198 | 90 | 5 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 5.22e-05 | 199 | 90 | 5 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 199 | 90 | 5 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.34e-05 | 200 | 90 | 5 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | distal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.34e-05 | 200 | 90 | 5 | 20112be28f80baffad92641c9cfd7c3718967dbb | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Fos_(dSPN,_IEG+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 45 | 90 | 3 | cce61a18a2d2ac9c3113ef7d9fe8adf70bad773c | |
| Disease | restless legs syndrome (implicated_via_orthology) | 1.04e-11 | 8 | 86 | 5 | DOID:0050425 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 2.10e-09 | 19 | 86 | 5 | DOID:1240 (implicated_via_orthology) | |
| Disease | Disorder of eye | 2.04e-07 | 212 | 86 | 8 | C0015397 | |
| Disease | MICROPHTHALMIA, ISOLATED 1 | 8.30e-07 | 7 | 86 | 3 | C1855052 | |
| Disease | Microphthalmos, Autosomal Recessive | 8.30e-07 | 7 | 86 | 3 | C4551977 | |
| Disease | Anophthalmia-microphthalmia syndrome | 3.06e-05 | 21 | 86 | 3 | cv:C5680330 | |
| Disease | Developmental delay (disorder) | 1.73e-04 | 37 | 86 | 3 | C0424605 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 2.32e-04 | 8 | 86 | 2 | C0796250 | |
| Disease | Anti-Toxoplasma gondii IgG measurement | 2.98e-04 | 9 | 86 | 2 | EFO_0009353 | |
| Disease | N-delta-acetylornithine measurement | 5.44e-04 | 12 | 86 | 2 | EFO_0800067 | |
| Disease | Global developmental delay | 6.29e-04 | 133 | 86 | 4 | C0557874 | |
| Disease | Animal Mammary Neoplasms | 8.04e-04 | 142 | 86 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 8.04e-04 | 142 | 86 | 4 | C1257925 | |
| Disease | photoreceptor cell layer thickness measurement | 9.38e-04 | 148 | 86 | 4 | EFO_0803370 | |
| Disease | Mammary Neoplasms, Experimental | 1.11e-03 | 155 | 86 | 4 | C0024668 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.17e-03 | 157 | 86 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Carcinomatosis | 1.34e-03 | 163 | 86 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.34e-03 | 163 | 86 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.34e-03 | 163 | 86 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.34e-03 | 163 | 86 | 4 | C0205696 | |
| Disease | Carcinoma | 1.37e-03 | 164 | 86 | 4 | C0007097 | |
| Disease | Retinal Degeneration | 1.70e-03 | 21 | 86 | 2 | C0035304 | |
| Disease | haptoglobin measurement | 1.70e-03 | 21 | 86 | 2 | EFO_0004640 | |
| Disease | nose morphology measurement, mouth morphology measurement | 1.70e-03 | 21 | 86 | 2 | EFO_0007843, EFO_0007955 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTRWRKQQQPVRRTV | 11 | Q6ZQR2 | |
| DWILQNRRHPQRNFI | 2361 | Q68DQ2 | |
| HQLPRERTIQQWLAR | 376 | O60477 | |
| RRLAPNFRWAIPNRQ | 41 | Q00994 | |
| NSQQRWTHIRLNIFP | 156 | Q8N6M5 | |
| RQQREKTRWLNSPNT | 431 | Q9UEY8 | |
| PRVQIWFQNERSRQL | 61 | P0CJ87 | |
| WRQQAECRQQRAIPS | 441 | O00468 | |
| LWNKYRERQRQQRQP | 3601 | Q8TCU4 | |
| PRVQIWFQNERSRQL | 61 | P0CJ89 | |
| IQARTPAQWRENSQL | 106 | Q9Y3E2 | |
| VTPQQQQRLASRWRS | 61 | O95622 | |
| QILWFRGLNRIQTQI | 1101 | Q16720 | |
| RLQERLPQSQTEWAQ | 666 | Q3KR37 | |
| WQEDFRELFRQPLRQ | 136 | Q8WXS8 | |
| LPEARVQIWFQNQRA | 121 | Q2M1V0 | |
| LPEVRVQVWFQNRRA | 66 | Q96IS3 | |
| LENPRRNRIAQWQSL | 166 | P20742 | |
| PVWAARRRLAQNALN | 131 | P05177 | |
| PQERQRQWIQISDAV | 261 | Q96TA1 | |
| ILQVNNWFINARRRI | 316 | O00470 | |
| DSVQQRVRQWLRPQE | 506 | O75808 | |
| RVRQWLRPQEINCSV | 511 | O75808 | |
| TEAVNFWQQLSRPRQ | 181 | O75610 | |
| PRVQIWFQNERSRQL | 61 | Q9UBX2 | |
| LQVNNWFINARRRIV | 321 | O14770 | |
| PESRIQIWFQNRRAR | 161 | Q96PT3 | |
| VQFNPGQTRATWRVR | 1826 | Q5SZK8 | |
| TVWQVRHLPQNRELF | 261 | Q96MX6 | |
| PRVQIWFQNERSRQL | 61 | P0CJ86 | |
| ENPMVQQFIQRWVRL | 276 | P42263 | |
| FWDSQRRRQPQPQRD | 961 | Q5VY43 | |
| VVQLRRQRPDFEWNE | 66 | Q6NV75 | |
| AQNIRNRATVNWRPE | 346 | Q2M1P5 | |
| QWRRQPTRLFVVVLA | 211 | Q8TDS7 | |
| ILQVNNWFINARRRI | 306 | Q99687 | |
| LWRSLSRNQRVNGQV | 206 | A6NGR9 | |
| NLTPRQRFRVAVWTV | 301 | P15735 | |
| ERLSRPNIFILNNRW | 246 | O95140 | |
| NLPESRVQVWFKNRR | 76 | P32242 | |
| QSARAQLWRELRDQP | 301 | Q8N0W3 | |
| ANRIYEILPQRIQQW | 401 | Q9P0U4 | |
| TRFSRRKIPWQQNFV | 1196 | Q6WRI0 | |
| WFQNNRARLPPEERQ | 71 | A0A1W2PPK0 | |
| RLQREPQVQWLEQQV | 86 | P09958 | |
| PRVQIWFQNERSRQL | 61 | Q6RFH8 | |
| LNTAFDRLRRVVPQW | 56 | Q8N100 | |
| RNPQELWRFLTQNLS | 156 | Q9BZC7 | |
| PESRIQLWFQNRRAR | 161 | Q96PT4 | |
| PRVQIWFQNERSRQL | 61 | P0CJ90 | |
| TEAVNFWQQLSRPRQ | 181 | O00292 | |
| GLRRQAIQNWQRRPR | 461 | Q8TF61 | |
| PRVQIWFQNERSCQL | 61 | O43812 | |
| PRSRWQVLTALRQRQ | 151 | A6NGE4 | |
| ARFIRVNPTQWQQKI | 426 | Q96PD2 | |
| PNWRKLRLITFNRNE | 31 | P56749 | |
| ENILNPLRRWNETFQ | 61 | Q9NRG7 | |
| PRVQIWFQNERSRQL | 61 | P0CJ88 | |
| RRFRQPQWQLLDPNA | 86 | Q9NSA0 | |
| PESRVQIWFQNRRSR | 141 | A6NLW8 | |
| NRRNANTFISPQQRW | 36 | P08493 | |
| TLLQVNNWFINARRR | 331 | Q96KN3 | |
| INLPESRVQVWFKNR | 76 | O43186 | |
| LTRNQAQQPFSLWAR | 226 | Q9UJX0 | |
| NLPESRVQVWFKNRR | 76 | P32243 | |
| LQVNNWFINARRRIV | 206 | A6NDR6 | |
| LGRNFLQWRRPTQQA | 2611 | Q5T011 | |
| EELQQNRRWNSREVP | 161 | A4D263 | |
| QISNWFINARRRILP | 96 | Q8IUE1 | |
| AQQRRGIIDSQIRQW | 7551 | Q8NF91 | |
| VNNWFINARRRILQP | 306 | P55347 | |
| WARERLEQQVPVNQV | 196 | P39023 | |
| YRVNIFLRQQWNDPR | 86 | P23415 | |
| IATRHPWNQFTRVQR | 891 | Q7Z443 | |
| RLNQTVIWDRPQVTF | 976 | P11215 | |
| QQQQRTREWVARHPQ | 301 | A6NEL2 | |
| PEVRVQVWFQNRRAK | 176 | Q9Y2V3 | |
| PWDQAVQRRSRLQRR | 21 | Q8TE77 | |
| RTVRIWRQYLPGNEQ | 216 | O76071 | |
| QQVRRRWESFVAIFP | 91 | A6NJI1 | |
| ELQRQRLEPFRQRLW | 611 | Q96EP0 | |
| WLFIREQRTQQQRSG | 46 | Q6J9G0 | |
| QQHQSWLRPVLRSNR | 51 | P00750 | |
| VRTNQIPRQIPEQRW | 481 | Q92544 | |
| PESRIQVWFQNRRAK | 126 | Q9H2W2 | |
| WRQQIFLRVATPQKA | 661 | Q86TI0 | |
| SVNPNRRLTSQQWRL | 211 | Q9NXF1 | |
| VSQLQGLWRRFNRPL | 141 | Q969D9 | |
| WREGRVFLQDQNPNR | 66 | A8MUZ8 | |
| QTPSVRKWALRRQNE | 251 | O75541 | |
| NQEINSDDRRPQWRR | 91 | Q9H2Y7 | |
| RRLVQLLRQHSSPWQ | 446 | O14746 | |
| LPTRVIVVWFQNARQ | 2281 | Q15911 | |
| FQVITINPRNSRWAE | 186 | Q8NFZ6 | |
| ELPEDRIQVWFQNRR | 186 | P58304 | |
| PRVQIWFQNERSRQL | 61 | P0CJ85 | |
| PEAQQLQRQVEQARW | 916 | P41229 | |
| WVMQPSIDIQLNRRQ | 431 | Q9NR99 | |
| TWRDQLRPTQLLQNV | 1666 | Q9NZM1 | |
| WQRVNAQTAVRSPRY | 556 | P54296 | |
| RPSFNRVAQGWVRNL | 231 | Q8TDC0 |